⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12208458 | 0.78 | LMNA (0.33) | — | |
| SCHEMBL8374381 | 0.78 | LMNA (0.39) | — | |
| SCHEMBL1005825 | 0.75 | HSD11B1 (0.31) | — | |
| SCHEMBL17888447 | 0.74 | ATM (0.31) | — | |
| SCHEMBL6956492 | 0.71 | — | — | |
| SCHEMBL6956499 | 0.71 | — | — | |
| SCHEMBL15048763 | 0.70 | — | — | |
| SCHEMBL6962132 | 0.70 | MAPK1 (0.52) | — | |
| SCHEMBL3242641 | 0.69 | — | — | |
| SCHEMBL157432 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0665216-B1 | Urea derivatives and their use as acat inhibitors | NISSHIN FLOUR MILLING CO (JP) | 1997-12-29 | — | — | EP | disclosed |
| US-5576335-A | TREATMENT OF HYPERCHOLESTEROLEMIA AND ATHEROSCLEROSIS | NISSHIN FLOUR MILLING CO., LTD. (JP) | 1996-11-19 | — | — | US | disclosed |
| EP-0665216-A1 | Urea derivatives and their use as acat inhibitors | NISSHIN FLOUR MILLING CO., LTD. (JP) | 1995-08-02 | — | — | EP | disclosed |